WOLVERINE ASSET MANAGEMENT LLC - PHOENIX BIOTECH ACQUISITION ownership

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K113. A total of 46 filers reported holding PHOENIX BIOTECH ACQUISITION in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q3 2023$6,293
+17.2%
87,8930.0%0.00%
Q2 2023$5,370
+52.4%
87,8930.0%0.00%
Q1 2023$3,524
-7.0%
87,8930.0%0.00%
Q4 2022$3,788
-36.9%
87,893
+8.9%
0.00%
Q3 2022$6,000
-25.0%
80,6890.0%0.00%
Q2 2022$8,000
-52.9%
80,6890.0%0.00%
Q1 2022$17,000
-48.5%
80,6890.0%0.00%
Q4 2021$33,00080,6890.00%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q3 2023
NameSharesValueWeighting ↓
Atalaya Capital Management LP 225,000$15,7500.02%
Q Global Advisors, LLC 170,785$120.01%
MMCAP International Inc. SPC 375,000$26,8500.01%
PERISCOPE CAPITAL INC. 957,098$68,5280.01%
CVI Holdings, LLC 44,106$3,1580.01%
Silver Rock Financial LP 12,224$8750.01%
Castle Creek Arbitrage, LLC 200,000$14,3200.00%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 714,827$51,1820.00%
Segantii Capital Management Ltd 5,000$54,3000.00%
GRITSTONE ASSET MANAGEMENT LLC 17,014$1,2180.00%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders